Search

everythinglearnresearchcommunity

for

Search:↓

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Melatonin may help treat PCOS symptoms in rats.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Boys with less severe EDA mutations in XLHED have milder symptoms and better sweat and hair production.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Baldness may lower the risk of testicular cancer.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

A new mutation in the HR gene is linked to a rare form of hair loss with limb deformities.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

PCOS may be influenced by factors in the blood, not just the ovaries.

DNMT3A is crucial for healthy skin and hair growth.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Hair follicle biology advancements may lead to better hair growth disorder treatments.